Medical Researcher - Neurologist for Alzheimer's Disease Clinical TrialsAbout the Company: IGC Pharma SAS, based in Bogota, is a subsidiary of an NYSE-listed U.S. start-up clinical-stage pharmaceutical company that focuses on preventing and managing Alzheimer's and other CNS diseases. We are committed to finding effective treatments through clinical research.
Job Description: As a Medical Doctor Neurologist, you will play a critical role in the execution of clinical trials for Alzheimer's disease treatments. You will be responsible for patient assessments, clinical evaluations, and the overall medical oversight of trial participants.
Key Responsibilities:Provide medical oversight for clinical trials, ensuring patient safety and the accurate collection of clinical data.Collaborate with clinical research coordinators, data managers, and regulatory teams to design and implement study protocols.Monitor the progression of Alzheimer's disease in participants and report on the effectiveness and safety of investigational treatments.Provide medical expertise in trial design, including patient selection criteria, endpoints, and safety assessments.Lead and participate in investigator meetings and contribute to scientific presentations and publications.Stay updated on emerging research, treatments, and trends in neurodegenerative diseases, especially Alzheimer's disease.Qualifications:Medical Doctor (MD) - Neurology.2-5 years of clinical experience, with a focus on neurodegenerative diseases, particularly Alzheimer's disease.Experience in clinical research or clinical trials, including protocol design and patient safety monitoring.Strong knowledge of neurodegenerative disease mechanisms, treatment approaches, and clinical endpoints.Excellent analytical, problem-solving, and decision-making skills.Strong written and verbal communication skills in English.Application Process: Interested candidates should submit their CV, cover letter, and any relevant clinical trial experience. Please include any publications or research contributions in Alzheimer's disease or neurodegenerative disorders.
#J-18808-Ljbffr